Expertise in
5
conditions

Dr. David Huffman

Endocrinology
David M. Huffman M.D. PC
5616 Brainerd Rd Ste 208, 
Chattanooga, TN 
Offers Telehealth
44 Years of Experience

Expertise in
5
conditions
David M. Huffman M.D. PC
5616 Brainerd Rd Ste 208, 
Chattanooga, TN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Huffman is an Endocrinologist in Chattanooga, Tennessee. Dr. Huffman has been practicing medicine for over 44 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Hashimoto Thyroiditis, Type 2 Diabetes (T2D), and Obesity in Children.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Endocrinology
Licenses
Internal Medicine in TN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 25 Less Insurance Carriers -

Locations

David M. Huffman M.D. PC
5616 Brainerd Rd Ste 208, Chattanooga, TN 37411
Call: 423-265-3561

Additional Areas of Focus

Dr. Huffman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Biological, Drug
Study Drugs: AG019 - Low Dose, Teplizumab, AG019 - High Dose, AG019 - Low or High Dose
Study Phase: Phase 1/Phase 2
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Diabetic Macular Edema Found by OCT Utilization at Non-ophthalmic Diabetes Care Visits
Enrollment Status: Completed
Publish Date: December 22, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

6 Total Publications

Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.
Automated Insulin Delivery in Adults With Type 2 Diabetes: A Nonrandomized Clinical Trial.
Journal: JAMA network open
Published: February 14, 2025
View All 6 Publications
Similar Doctors
Expertise in
45
conditions
Dr. Prashanth Sekhar
Endocrinology
Expertise in
45
conditions
Dr. Prashanth Sekhar
Endocrinology

CHI Memorial Arthritis And Rheumatology Associates

725 Glenwood Dr Ste E588, 
Chattanooga, TN 
 (3.5 miles away)
423-206-9025
Languages Spoken:
English
See accepted insurances

Prashanth Sekhar is an Endocrinologist in Chattanooga, Tennessee. Dr. Sekhar is highly rated in 45 conditions, according to our data. His top areas of expertise are Thyroid Storm, Hyperthyroidism, Hyperparathyroidism, and Type 2 Diabetes (T2D).

Expertise in
28
conditions
Dr. Ana Cornea
Endocrinology
Expertise in
28
conditions
Dr. Ana Cornea
Endocrinology

Specialty

2205 McCallie Ave, 
Chattanooga, TN 
 (3.5 miles away)
423-698-2435
Languages Spoken:
English
See accepted insurances

Ana Cornea is an Endocrinologist in Chattanooga, Tennessee. Dr. Cornea is highly rated in 28 conditions, according to our data. Her top areas of expertise are Thyroid Nodule, Hypothyroidism, Obesity in Children, and Type 1 Diabetes (T1D).

Expertise in
23
conditions
Dr. Rita Shridharani
Endocrinology
Expertise in
23
conditions
Dr. Rita Shridharani
Endocrinology

Children's Hospital At Erlanger Endocrinology

900 E 3rd St, 
Chattanooga, TN 
 (5.1 miles away)
423-778-5437
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rita Shridharani is an Endocrinologist in Chattanooga, Tennessee. Dr. Shridharani is highly rated in 23 conditions, according to our data. Her top areas of expertise are Acanthosis Nigricans, Type A Insulin Resistance Syndrome, Precocious Puberty, and Short Stature (Growth Disorders).

VIEW MORE Endocrinologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Huffman's expertise for a condition
ConditionClose
    • Distinguished
    • Type 1 Diabetes (T1D)
      Dr. Huffman is
      Distinguished
      . Learn about Type 1 Diabetes (T1D).
      See more Type 1 Diabetes (T1D) experts
    • Advanced
    • Hashimoto Thyroiditis
      Dr. Huffman is
      Advanced
      . Learn about Hashimoto Thyroiditis.
      See more Hashimoto Thyroiditis experts
    • Hypothyroidism
      Dr. Huffman is
      Advanced
      . Learn about Hypothyroidism.
      See more Hypothyroidism experts
    • Obesity in Children
      Dr. Huffman is
      Advanced
      . Learn about Obesity in Children.
      See more Obesity in Children experts
    • Type 2 Diabetes (T2D)
      Dr. Huffman is
      Advanced
      . Learn about Type 2 Diabetes (T2D).
      See more Type 2 Diabetes (T2D) experts
    • Experienced
    • Abdominal Obesity Metabolic Syndrome
      Dr. Huffman is
      Experienced
      . Learn about Abdominal Obesity Metabolic Syndrome.
      See more Abdominal Obesity Metabolic Syndrome experts
    • Addison's Disease
      Dr. Huffman is
      Experienced
      . Learn about Addison's Disease.
      See more Addison's Disease experts
    • Adrenal Insufficiency Pediatric
      Dr. Huffman is
      Experienced
      . Learn about Adrenal Insufficiency Pediatric.
      See more Adrenal Insufficiency Pediatric experts
    • Alopecia Areata
      Dr. Huffman is
      Experienced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Autosomal Recessive Hypotrichosis
      Dr. Huffman is
      Experienced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Cytochrome C Oxidase Deficiency
      Dr. Huffman is
      Experienced
      . Learn about Cytochrome C Oxidase Deficiency.
      See more Cytochrome C Oxidase Deficiency experts
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Endocrinologists Chattanooga, TN
    3. Dr. David Huffman
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

      Patient Details

      This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.